Murat Celebi is busy meeting innovative MedTech companies at CIRSE2019
BAUS, EAU and NICE have suggested that hospitals switch to our EMDA®+Mitomycin-C treatment due to the worldwide shortage of BCG.
We are counting down to BAUS 2019 in Glasgow next week.
EuroPCR 2019 proved as informative as ever with Robin Luper delighted to share the benefits of the RenalGuard System™ with new contacts as well as catching up with colleagues.
Physion has appointed JS Consulting as their strategic advisor for the GCC & Middle East regions.
Following the recommendation in January 2019 by NICE to use EMDA® in research programmes as a treatment for bladder cancer, JS Medical has taken steps to ensure there will be no change to our delivery schedules in coming months.
NICE has called for EMDA® to be used in research programmes as a treatment for bladder cancer.
Expanding Internationally ….. Sounds exciting, but perhaps also daunting – however don’t be overwhelmed by the prospect of opening overseas when our experts are ready to help you succeed. Robin Luper and Murat Celebi will be in attendance at Medica in Dusseldorf from 12-15 November and look forward to connecting with companies
JS Medical, previously known as Jump Start Consulting Limited, is now officially based at Cranfield’s Innovation Centre at the Cranfield Technology Park, home to nearly 60 science, technology and knowledge-based businesses.